PFBT
RXRX icon

Parkside Financial Bank & Trust’s Recursion Pharmaceuticals RXRX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.48K Hold
2,110
– – ﹤0.01% 1739
2025
Q4 		$8.63K Sell
2,110
-9
-0.4% -$45 ﹤0.01% 1630
2025
Q3 		$10.3K Buy
2,119
+2,019
+2,019% +$10.6K ﹤0.01% 1507
2025
Q2 		$506 Sell
100
-65
-39% -$319 ﹤0.01% 2548
2025
Q1 		$873 Buy
+165
New +$1.2K ﹤0.01% 2161

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Parkside Financial Bank & Trust's RXRX Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Recursion Pharmaceuticals (RXRX) position steady in Q1 2026 at 2,110 shares worth $6.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Parkside Financial Bank & Trust first reported a position in RXRX in Q1 2025 and has held it in 5 quarters since. The position peaked at $10.3K in Q3 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Parkside Financial Bank & Trust held 2,110 shares of Recursion Pharmaceuticals worth $6.48K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Recursion Pharmaceuticals share count unchanged in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1739 holding.
  • Parkside Financial Bank & Trust first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Recursion Pharmaceuticals position peaked at $10.3K in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.